Multi-omics characterization of metabolic and immune interactions in prostate cancer
<i>ENO1</i> and <i>CKB</i> serve as clinically meaningful markers-<i>ENO1</i> indicating metastatic potential and <i>CKB</i> predicting overall prognosis-while also representing promising therapeutic targets. These findings bridge molecular metabolism-immune crosstalk with clinical outcomes, offering novel perspectives for integrating metabolic intervention and immunotherapy in PCa management.
Authors
- Yichun Fu (ORCID: https://orcid.org/0000-0001-5620-3200)
- Fengxia Wang (ORCID: https://orcid.org/0000-0003-3478-8863)
- Jinfeng Wu (ORCID: https://orcid.org/0009-0004-6129-4425)
Institutions
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- Translational Andrology and Urology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.21037/tau-2025-502
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00